* Low cost of production and R&D boosts efficiency of Indian pharma companies, leading to competitive exports.
* Indian drugs and pharma exports reached US$ 5.78 billion between April 2021- June 2021.
* High economic growth along with increasing penetration of health insurance to push expenditure on healthcare and medicine in India.
* In June 2021, Finance Minister Ms. Nirmala Sitharaman announced an additional outlay of Rs. 197,000 crore (US$ 26,578.3 million) that will be utilised over five years for the pharmaceutical PLI scheme in 13 key sectors such as active pharmaceutical ingredients, drug intermediaries and key starting materials.
* The FDI inflows in the Indian drugs and pharmaceuticals sector reached US$ 1.206 billion between April-December 2021.
Indian pharma company have won around 40 per cent of all Abbreviated New Drug Approval (ANDA) from the US Food and Drug Administration (FDA) between january and july 2013.
From the small towns and districts of India come the big-hearted artists wh...
The Geographical Indications Registry is set up for administration of the G...
The Merchandise Industry of India India's share in global merchandise ...
Introduction to Blue Economy Blue Economy is defined by the World Bank as ...
India's Automobile Industry India is the fifth largest vehicle market ...